BIVI
Price
$1.65
Change
-$0.01 (-0.60%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
3.06M
ITOS
Price
$10.11
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
446.92M
81 days until earnings call
Interact to see
Advertisement

BIVI vs ITOS

Header iconBIVI vs ITOS Comparison
Open Charts BIVI vs ITOSBanner chart's image
BioVie
Price$1.65
Change-$0.01 (-0.60%)
Volume$1.06K
Capitalization3.06M
iTeos Therapeutics
Price$10.11
Change-$0.00 (-0.00%)
Volume$1.47M
Capitalization446.92M
BIVI vs ITOS Comparison Chart in %
Loading...
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIVI vs. ITOS commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVI is a Hold and ITOS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (BIVI: $1.65 vs. ITOS: $10.11)
Brand notoriety: BIVI and ITOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIVI: 76% vs. ITOS: 119%
Market capitalization -- BIVI: $3.06M vs. ITOS: $446.92M
BIVI [@Biotechnology] is valued at $3.06M. ITOS’s [@Biotechnology] market capitalization is $446.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIVI’s FA Score shows that 1 FA rating(s) are green whileITOS’s FA Score has 1 green FA rating(s).

  • BIVI’s FA Score: 1 green, 4 red.
  • ITOS’s FA Score: 1 green, 4 red.
According to our system of comparison, ITOS is a better buy in the long-term than BIVI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIVI’s TA Score shows that 4 TA indicator(s) are bullish while ITOS’s TA Score has 4 bullish TA indicator(s).

  • BIVI’s TA Score: 4 bullish, 4 bearish.
  • ITOS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BIVI and ITOS are a good buy in the short-term.

Price Growth

BIVI (@Biotechnology) experienced а -1.20% price change this week, while ITOS (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

ITOS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITOS($447M) has a higher market cap than BIVI($3.06M). ITOS YTD gains are higher at: 31.641 vs. BIVI (-91.750). BIVI has higher annual earnings (EBITDA): -18M vs. ITOS (-146.71M). ITOS has more cash in the bank: 520M vs. BIVI (8.01M). BIVI has less debt than ITOS: BIVI (366K) vs ITOS (5.05M). ITOS has higher revenues than BIVI: ITOS (35M) vs BIVI (0).
BIVIITOSBIVI / ITOS
Capitalization3.06M447M1%
EBITDA-18M-146.71M12%
Gain YTD-91.75031.641-290%
P/E RatioN/AN/A-
Revenue035M-
Total Cash8.01M520M2%
Total Debt366K5.05M7%
FUNDAMENTALS RATINGS
BIVI: Fundamental Ratings
BIVI
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
99
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIVIITOS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 24 days ago
83%
Bullish Trend 11 days ago
72%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 25 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HQICX21.40N/A
N/A
Hartford Equity Income C
PREFX83.99N/A
N/A
T. Rowe Price Tax-Efficient Equity
GGHPX8.13N/A
N/A
Goldman Sachs Intl Eq Div & Prem P
PETZX14.59N/A
N/A
Gabelli Pet Parents'™
TVCFX65.15-0.44
-0.67%
Thornburg Small/Mid Cap Core C

BIVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIVI has been loosely correlated with HURA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BIVI jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIVI
1D Price
Change %
BIVI100%
-0.60%
HURA - BIVI
45%
Loosely correlated
+10.87%
HOFBF - BIVI
44%
Loosely correlated
N/A
SCNI - BIVI
34%
Loosely correlated
-12.64%
LGVN - BIVI
31%
Poorly correlated
+0.64%
ITOS - BIVI
27%
Poorly correlated
N/A
More